Efficacy and cost-effectiveness of clofarabine with high-dose cytarabine for treatment of relapsed/refractory acute myeloid leukemia (R/R AML).

被引：0
|
作者：
Nunnery, Sara [1 ]
Wang, Dorothy [1 ]
Tan, Marisela [1 ]
Fong, Richard [1 ]
Lo, Mimi Ming [1 ]
Olin, Rebecca L. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e19009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19009
引用
收藏
页数：2
相关论文
共 50 条
  • [41] High Dose Cytarabine, Mitoxantrone and L-Asparaginase (HAMA) Salvage For Relapsed Or Refractory Acute Myeloid Leukemia (AML) In The Elderly
    Ahmed, Tamjeed
    Holwerda, Scott
    Pardee, Timothy
    Isom, Scott
    Lyerly, Susan
    Ellis, Leslie Renee
    Manuel, Megan
    Dralle, Sarah
    Dmitriy, Berenzon
    Klepin, Heidi D.
    Powell, Bayard L.
    BLOOD, 2013, 122 (21)
  • [42] High dose cytarabine, mitoxantrone and L-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly
    Ahmed, Tamjeed
    Holwerda, Scott
    Klepin, Heidi D.
    Isom, Scott
    Ellis, Leslie R.
    Lyerly, Susan
    Manuel, Megan
    Dralle, Sarah
    Berenzon, Dmitriy
    Powell, Bayard L.
    Pardee, Timothy S.
    LEUKEMIA RESEARCH, 2015, 39 (09) : 945 - 949
  • [43] Pooled Safety Analysis of Quizartinib Monotherapy in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
    Cortes, Jorge E.
    Ganguly, Siddhartha
    Kraemer, Alwin
    Levis, Mark J.
    Martinelli, Giovanni
    Perl, Alexander E.
    Russell, Nigel H.
    Choi, Youngsook
    Mendell, Jeanne
    Namuyinga, Ruth
    Hoang Pham
    Said, Nabil
    Wang, Yibin
    Mitov, Tsvetomir
    Kim, Ben
    Khaled, Samer K.
    BLOOD, 2019, 134
  • [44] A Phase IB/II Study of Lirilumab with Azacytidine in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
    Daver, Naval
    Boddu, Prajwal
    Ravandi, Farhad
    Jabbour, Elias
    Borthakur, Gautam
    DiNardo, Courtney
    Konopleva, Marina
    Pemmaraju, Naveen
    Kadia, Tapan
    Jain, Nitin
    Pierce, Sherry
    Hussain, Nawar
    Ning, Jing
    Nogueras-Gonzalez, Graciela
    Basu, Sreyashi
    Cortes, Jorge
    Sharma, Padmanee
    Kantarjian, Hagop
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (10): : S6 - S7
  • [45] Outcomes of six-dose high-dose cytarabine (HiDAC-6) as a salvage regimen for patients with relapsed/refractory acute myeloid leukemia (RR-AML).
    Veltri, Lauren Westfall
    Anders, Brandi
    Kanate, Abraham Sebastian
    Shillingburg, Alexandra
    Craig, Michael D.
    Cumpston, Aaron
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [46] A Phase 1 Trial of Valemetostat in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)
    Erba, Harry P.
    Oluwole, Olalekan O.
    Bixby, Dale
    Rampal, Raajit K.
    Fathi, Amir T.
    Paliwal, Prashni
    Jin, Jin
    Inoue, Ai
    Daver, Naval
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S311 - S312
  • [47] HIGH DOSE CYTARABINE, CLOFARABINE AND GEMTUZUMAB OZOGAMICIN (CLAC-MYL) IN RELAPSED OR REFRACTORY AML PATIENTS
    Scappini, B. S.
    Gianfaldoni, G.
    Susini, M. C.
    Fanci, R.
    Baldini, S.
    Fjerza, R.
    Mannelli, F.
    Longo, G.
    Bosi, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 549 - 549
  • [48] A Real-World Study on Clofarabine and Cytarabine Combination in Patients with Relapsed/Refractory Acute Myeloid Leukemia
    Crobu, Valeria
    Caocci, Giovanni
    La Nasa, Giorgio
    Saderi, Laura
    Sotgiu, Giovanni
    Fozza, Claudio
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2019, 11
  • [49] EFFICACY AND SAFETY OF RITUXIMAB AND HIGH-DOSE DEXAMETHASONE (R-DEX) IN THE TREATMENT OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
    Simkovic, M.
    Belada, D.
    Motyckova, M.
    Zak, P.
    Smolej, L.
    HAEMATOLOGICA, 2013, 98 : 542 - 543
  • [50] Outcomes with Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine as Salvage Therapy for Relapsed/Refractory Acute Myeloid Leukemia
    Boddu, Prajwal
    Jain, Nitin
    Ravandi, Farhad
    Manero, Guillermo Garcia
    Borthakur, Gautam
    Kadia, Tapan
    Jabbour, Elias J.
    Pemmaraju, Naveen
    Clatter, Naval
    DiNardo, Courtney D.
    Konopleva, Marina
    Alvarado, Yesid
    Takahashi, Koichi
    Benton, Christopher
    Pike, Allison
    Pierce, Sherry
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (10): : S3 - S4
12345